However, the prognosis of DLBCL with MYC rearrangement, which regulates multiple functions including cell cycle progression, cell proliferation, apoptosis, and glucose metabolism, remains poor with a median overall survival of less than 1 year [2–10]. Here, MYC is linked to diffuse large B-cell lymphoma.